Collegium Pharmaceutical (COLL) Interest Coverage Ratio Growth (3y) (2017 - 2026)
Collegium Pharmaceutical (COLL) Interest Coverage Ratio Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Collegium Pharmaceutical | 879.69 Mn | 730.37 Mn | 110.29 Mn | -51.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -75.03% |
| Mar 31, 2026 | -33.43% |
| Dec 31, 2025 | 76.64% |
| Sep 30, 2025 | 40.35% |
| Jun 30, 2025 | 42.27% |
| Mar 31, 2025 | 59.04% |
| Dec 31, 2024 | 30.74% |
| Sep 30, 2024 | -38.92% |
| Jun 30, 2024 | 49.32% |
| Mar 31, 2024 | -8.43% |
| Dec 31, 2023 | 18.18% |
| Sep 30, 2023 | 95.04% |
| Jun 30, 2023 | 87.73% |
| Mar 31, 2023 | 148.02% |
| Dec 31, 2022 | 27.05% |
| Sep 30, 2022 | 28.86% |
| Jun 30, 2022 | 28.87% |
| Mar 31, 2022 | 85.90% |
| Dec 31, 2021 | -52.80% |
| Sep 30, 2021 | 177.81% |